• AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

  • Dec 19 2023
  • Length: 41 mins
  • Podcast

AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy cover art

AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

  • Summary

  • In this episode, Anthony and Bernie discuss the AML abstracts at ASH that we found most intriguing and controversial!

    Abstracts:

    • FILO - Stopping Aza/Ven: https://ash.confex.com/ash/2023/webprogram/Paper185437.html
    • Revumenib Late Breaking Abstract: https://ash.confex.com/ash/2023/webprogram/Paper192042.html
    • JNJ617 Menin Inhibitor Data: https://ash.confex.com/ash/2023/webprogram/Paper172422.html
    • SAVE Trial (Revumenib + PO Dec/ven): https://ash.confex.com/ash/2023/webprogram/Paper182337.html
    • Dec/Ven vs. 3+7 Randomized Phase II: https://ash.confex.com/ash/2023/webprogram/Paper181347.html
    • NCRI AML18 RCT: https://ash.confex.com/ash/2023/webprogram/Paper185956.html
    • Impact of NPM1+/FLT3+/MRD in AML17 and AML19: https://ash.confex.com/ash/2023/webprogram/Paper179033.html
    • CBF and NPM1 MRD: https://ash.confex.com/ash/2023/webprogram/Paper184848.html
    • Persistent MRD by PCR but Flow Negativity in CBF AML (Mast Cell Madness): https://ash.confex.com/ash/2023/webprogram/Paper180275.html
    • MORPHO More MRD Analysis: https://ash.confex.com/ash/2023/webprogram/Paper177929.html
    Show More Show Less

What listeners say about AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.